THQM — Tchaikapharma High Quality Medicines AD Income Statement
0.000.00%
Last trade - 00:00
- BGN1.46bn
- BGN1.47bn
- BGN48.55m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.7 | 40.4 | 42.6 | 43.2 | 48.6 |
Cost of Revenue | |||||
Gross Profit | 12.4 | 11.2 | 12.9 | 13.1 | 15.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.8 | 39.8 | 41.1 | 40.8 | 44.6 |
Operating Profit | 2.95 | 0.539 | 1.46 | 2.33 | 3.97 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.96 | 0.624 | 1.57 | 3.13 | 3.87 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.57 | 0.604 | 1.4 | 2.79 | 3.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.57 | 0.604 | 1.4 | 2.79 | 3.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.57 | 0.604 | 1.4 | 2.79 | 3.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.036 | 0.016 | 0.027 | 0.039 | 0.049 |
Dividends per Share |